About

Andrea Mari is a prominent urological surgeon and clinical researcher whose work has profoundly shaped the field of minimally invasive kidney surgery. His research centers on robot-assisted and laparoscopic partial nephrectomy, renal oncology, and the optimization of surgical techniques to preserve kidney function while achieving oncological control. Mari has been a driving force behind landmark multicenter studies, including the RECORd and RECORd 2 projects, which systematically compared open, laparoscopic, and robotic approaches to partial nephrectomy across large patient cohorts, together accumulating over 260 citations. His leadership in the ROSULA and CLOCK randomized controlled trials further established critical evidence on clamping strategies and outcomes for complex renal tumors, with the CLOCK trial alone garnering over 100 citations. Notably, Mari introduced a refined "trifecta" framework for evaluating robot-assisted partial nephrectomy, improving standardization in outcome reporting globally. His contributions extend to upper tract urothelial carcinoma through the ROBUUST Collaborative Group. With a body of work exceeding 900 cumulative citations across his most impactful publications, Mari represents a leading voice in evidence-based urological oncology.

Research Focus

Key Achievements

34
H-Index
117
Papers
3,123
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group)
147 citations · 2018
📈 Most Prolific Year: 2020 (24 Papers)
🤝 Key Collaborators: 622
🏛 Institutions: University of Florence, Azienda Ospedaliero-Universitaria Careggi, Temple University, Centro de Cirugía de Mínima Invasión Jesús Usón

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 0 days ago